» Articles » PMID: 26034364

Cholecystectomy is Independently Associated with Nonalcoholic Fatty Liver Disease in an Asian Population

Overview
Specialty Gastroenterology
Date 2015 Jun 3
PMID 26034364
Citations 31
Authors
Affiliations
Soon will be listed here.
Abstract

Aim: To investigate the relationship between gallstone disease and nonalcoholic fatty liver disease (NAFLD) in a large Asian population.

Methods: A cross-sectional study including 17612 subjects recruited from general health check-ups at the Seoul National University Hospital, Healthcare System Gangnam Center between January 2010 and December 2010 was conducted. NAFLD and gallstone disease were diagnosed based on typical ultrasonographic findings. Subjects who were positive for hepatitis B or C, or who had a history of heavy alcohol consumption (> 30 g/d for men and > 20 g/d for women) or another type of hepatitis were excluded. Gallstone disease was defined as either the presence of gallstones or previous cholecystectomy, and these two entities (gallstones and cholecystectomy) were analyzed separately. Clinical parameters including body mass index, waist circumference, hypertension, diabetes, smoking status, and regular physical activity were reviewed. Laboratory parameters, including serum levels of gamma-glutamyl transpeptidase, alanine aminotransferase, aspartate aminotransferase, fasting glucose, fasting insulin, total cholesterol, triglycerides, and high-density lipoprotein, were also reviewed.

Results: The mean age of the subjects was 48.5 ± 11.3 years, and 49.3% were male. Approximately 30.3% and 6.1% of the subjects had NAFLD and gallstone disease, respectively. The prevalence of gallstone disease (8.3% vs 5.1%, P < 0.001), including both the presence of gallstones (5.5% vs 3.4%, P < 0.001) and a history of cholecystectomy (2.8% vs 1.7%, P < 0.001), was significantly increased in the NAFLD group. In the same manner, the prevalence of NAFLD increased with the presence of gallstone disease (41.3% vs 29.6%, P < 0.001). Multivariate regression analysis showed that cholecystectomy was associated with NAFLD (OR = 1.35, 95%CI: 1.03-1.77, P = 0.028). However, gallstones were not associated with NAFLD (OR = 1.15, 95%CI: 0.95-1.39, P = 0.153). The independent association between cholecystectomy and NAFLD was still significant after additional adjustment for insulin resistance (OR = 1.45, 95%CI: 1.01-2.08, P = 0.045).

Conclusion: This study shows that cholecystectomy, but not gallstones, is independently associated with NAFLD after adjustment for metabolic risk factors. These data suggest that cholecystectomy may be an independent risk factor for NAFLD.

Citing Articles

The effect of cholecystectomy for symptomatic gall stone disease on hepatic steatosis using transabdominal ultrasonography: An observational prospective study.

Dhakaria U, Kumar Bansiwal R, Kavita Khemchand A, Sharma R, Singh M, Kaur N Turk J Surg. 2025; 40(4):320-327.

PMID: 39980651 PMC: 11831990. DOI: 10.47717/turkjsurg.2024.6593.


Diagnostic accuracy of Fatty Liver Index (FLI) for detecting Metabolic Associated Fatty Liver Disease (MAFLD) in adults attending a tertiary care hospital, a cross-sectional study.

Vamja R, M Y, Vala V, Ramachandran A, Nagda J Clin Diabetes Endocrinol. 2024; 10(1):46.

PMID: 39668382 PMC: 11639111. DOI: 10.1186/s40842-024-00197-2.


Metabolic Dysfunction Associated Fatty Liver Disease in Long-Term Cholecystectomy Patients: A Cross-Sectional Study.

Sezer S, Demirci S, Kara M Turk J Gastroenterol. 2024; .

PMID: 39632671 PMC: 11900042. DOI: 10.5152/tjg.2024.24337.


Cholecystectomy Increases the Risk of Chronic Kidney Disease: A Nationwide Longitudinal Cohort Study.

Heo J, Kim E, Jung H, Han K, Kang J, Lee S J Clin Med. 2024; 13(21).

PMID: 39518737 PMC: 11545971. DOI: 10.3390/jcm13216598.


Liver Fibrosis and Cirrhosis in Patients with Non-alcoholic Fatty Liver with and without History of Cholecystectomy: A Pilot Study.

Parsi A, Hajiani E, Sadani S, Hashemi S, Seyedian S, Alimadadi M Middle East J Dig Dis. 2024; 16(1):34-38.

PMID: 39050095 PMC: 11264833. DOI: 10.34172/mejdd.2024.366.


References
1.
Bae J, Rhee E, Lee W, Park S, Park C, Oh K . Combined effect of nonalcoholic fatty liver disease and impaired fasting glucose on the development of type 2 diabetes: a 4-year retrospective longitudinal study. Diabetes Care. 2011; 34(3):727-9. PMC: 3041216. DOI: 10.2337/dc10-1991. View

2.
Alisi A, Ceccarelli S, Panera N, Prono F, Petrini S, De Stefanis C . Association between Serum Atypical Fibroblast Growth Factors 21 and 19 and Pediatric Nonalcoholic Fatty Liver Disease. PLoS One. 2013; 8(6):e67160. PMC: 3694051. DOI: 10.1371/journal.pone.0067160. View

3.
Targher G, Bertolini L, Poli F, Rodella S, Scala L, Tessari R . Nonalcoholic fatty liver disease and risk of future cardiovascular events among type 2 diabetic patients. Diabetes. 2005; 54(12):3541-6. DOI: 10.2337/diabetes.54.12.3541. View

4.
Nervi F, Arrese M . Cholecystectomy and NAFLD: does gallbladder removal have metabolic consequences?. Am J Gastroenterol. 2013; 108(6):959-61. DOI: 10.1038/ajg.2013.84. View

5.
Giamberardino M, Affaitati G, Lerza R, Lapenna D, Costantini R, Vecchiet L . Relationship between pain symptoms and referred sensory and trophic changes in patients with gallbladder pathology. Pain. 2005; 114(1-2):239-49. DOI: 10.1016/j.pain.2004.12.024. View